Globalstar, Inc. (OTCBB: GSAT) recently announced that it received a delisting notice from NASDAQ do to the fact that it's share price has fallen below $1.00 per share in excess of the time period permitted by NASDAQ rules. The company after a recent appeal to NASDAQ requested a further extension and was denied.
The six time patent infringement in pharmaceuticals case plaintiff Depomed (NASDAQ: DEPO) is making progress in battles. Watson Pharmaceuticals (NYSE: WPI) withdrew its application for the competing drug generic Gralise, and the suit against Impax Laboratories (NASDAQ: IPXL) was dismissed after the withdrawal of their application. The road is getting clearer as the competition is fading. Look for Depomed to react.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts